Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Frias et al., Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial, Lancet Lond
Eine abschlieende Datenlage dazu gibt es nicht
Calo, L
Constipation, Bloating, and Diarrhea The slowed motility affects your entire digestive tract
US$ 22.66
)
US$ 24.66
US$ 23.19
US$ 26.53
)
US$ 28.14
